A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer Which Could Not Be Controlled

Conditions: Non-Small Cell Lung Carcinoma Interventions: Drug: Lorlatinib Sponsors: Pfizer Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials